Arellano FM, Yood MU, Wentworth CE, Oliveria SA, Rivero E, Arana A, Rothman KJ. Use of Cyclo-Oxygenase 2 Inhibitors (COX-2) and prescription Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) in UK and USA populations. Pharmacoepidemiol Drug Saf. 2008 Oct 1;17(10):1037. doi: 10.1002/pds.1636
Arana A, Arellano FM, Rivero E, Pavesi M, Dey D, Wentworth CW. Intravitreal (IVT) injection-related ocular adverse events in the general population of the United States of America. Poster presented at the 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2008. Copenhagen, Denmark. [abstract] Pharmacoepidemiol Drug Saf. 2008 Aug; 17(Suppl 1):S75-6.
Wentworth CW, Arellano FM, Rivero E, Pavesi M, Dey D, Arana A. Use of intravitreal (IVT) injection therapies in the general population of the United States of America. Presented at the 24th International Conference on Pharmacoepidemiology; August 2008. Copenhagen, Denmark. [abstract] Pharmacoepidemiol Drug Saf. 2008 Aug; 17(Suppl 1):S251-2.
Arana A, Arellano FM, Rivero E, Parvesi M, Dey D, Wentworth CE. Intravitreal (IVT) injectionrelated ocular adverse events in the general population of the United States of America. Presented at the 24th International Conference on Pharmacoepidemiology; 2008.
Arellano FM, Arana A, Wentworth CE. Occurrence of lymphoma among patients with atopic dermatitis and/or treated with topical immunosuppressants in the United Kingdom. Presented at the 24th International Conference on Pharmacoepidemiology; 2008.
Conde E, Arellano FM, Wentworth CE, Schlienger R, Fernández-Vidaurre C, Arana A. Validation of cases of lymphoma in THIN. Presented at the 24th International Conference on Pharmacoepidemiology; 2008.
Arana A, Arellano FM. Cancer incidence near oilfields in the Amazon basin of Ecuador revisited. Occup Environ Med. 2007;64(7):490.
Arana A, Wentworth CE, Conde E. Cancer incidence in patients with and without atopic dermatitis in the United Kingdom. Presented at the 23rd International Conference on Pharmacoepidemiology; 2007.
Arana A, Arellano FM, Wentworth CE. Cancer incidence in patients with and without atopic dermatitis in the United Kingdom. Presented at the Annual Meeting of the Society for Investigative Dermatology; 2007. Previously presented at the 23rd International Conference on Pharmacoepidemiology.
Arellano FM, Wentworth CE, Arana A, Fernández C, Paul CF. Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis. J Invest Dermatol. 2007;127(4):808-16.
Arellano FM, Wentworth CE, Conde E, Schlienger R, Fernández-Vidaurre C, Arana A. Incidencia de cáncer en pacientes con y sin atópica dermatitis en Inglaterra. Presented at the VII Jornadas de Farmacovigilancia; 2007.
Arellano FM, Arana A, Wentworth CE. Risk of lymphoma among users of topical corticosteroids and topical calcineurin inhibitors. Presented at the Annual Meeting of the Society for Investigative Dermatology; 2007.
Arana A, Castellsague J, Trave F, Perez-Gutthann S, Rothman KJ, Arellano FM. Early estimation of excess risk of serious cutaneous reactions for newly marketed drugs. Poster presented at the 1st International Conference on Therapeutic Risk Management & 19th ICPE International Conference on Pharmacoepidemiology; August 2003. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2003 Aug; 12(S1):165.
Arana A, Broeckmans AW. Validity of epidemiological research conducted following Good Clinical Practice Guidelines. Presented at the 19th International Conference on Pharmacoepidemiology; 2003.
Tuells A, Arana A, Perez-Gutthann S, García-Rodríguez LA. El Proyecto BIFAP. Inv Clin Farm. 2003;0:25-6.
Sánchez Matienzo D, Gimeno V, Castellsague J, Arana A. Safety profile of smell and taste disorders in patients treated with cox-2 specific inhibitors and other selected drugs. Presented at the 19th International Conference on Pharmacoepidemiology; 2003.
Sánchez Matienzo D, Gimeno V, Castellsague J, Arana A. A comparative safety profile of serious skin and hypersensitivity reactions: cOX-s specific inhibitors vs. non-selective NSAIDs and other selected drugs. Presented at the 19th International Conference on Pharmacoepidemiology; 2003. [abstract] Pharmacoepidemiol Drug Saf. 2003; 12(S1):S185.
Sánchez Matienzo D, Gemino V, Castellsague J, Arana A. Safety profile analysis of liver disorders in patients treated with celecoxib and rofecoxib. Presented at the 19th International Conference on Pharmacoepidemiology; 2003.